LOMA Q1 2026 Earnings Strong EPS of 3505 Despite Negative Stock Reaction FWDI Q1 2026 Earnings Strong EPS Beat Drives Profitability Despite Revenue Uncertainty Addex Therapeutics Q1 2024 Earnings PreRevenue Biotech Advances Pipeline Amid Narrowing Losses FTNT Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Unavailable Diamond Hill Investment Group Q1 2025 Earnings Steady EPS Amid Quiet Market Response MRCY Q1 2026 Earnings Massive EPS Surprise of 284 Drives Stock Higher STRZ Q1 2026 Earnings Massive EPS Miss Overshadows Modest Stock Gain CFFN Q1 2026 Earnings EPS Misses Estimates Amid Narrowing Net Interest Margin AUPH Q1 2026 Earnings EPS Surges Past Estimates Stock Slides Despite Strong BottomLine Performance EMBJ Q1 2026 Earnings EPS Falls Short of Estimates as Shares Edge Higher TCBI Q1 2026 Earnings EPS Surpasses Expectations by 898 as Shares Edge Lower EW Q1 2026 Earnings EPS Beat Drives Stock Higher Amid Limited Revenue Disclosure Reviva Pharmaceuticals RVPH Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage